🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yan Jin

Eli Lilly (United States)

ORCID: 0000-0001-7547-1841
Pharmacology, Toxicology and PharmaceuticsMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor.

1 citations

Yan Jin, Chunhong Shao, Xiaoqiao Zhang, Guang Yang, Jing Shao

2 citations

Ying Grace Li, Stephen D. Hall, Jenny Y. Chien, Christopher D. Payne, Maria M. Posada +3 more